Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
Cell Biol Toxicol. 2022 Aug;38(4):629-648. doi: 10.1007/s10565-021-09666-1. Epub 2021 Oct 22.
Aristolochic acid nephropathy (AAN) is a progressive kidney disease caused by some herbal medicines, but treatment remains ineffective. We previously found that leucine-rich α-2-glycoprotein 1 (LRG1), which regulates cellular processes, plays an important role in a kidney injury model. However, the underlying mechanism by which LRG1 regulates AAN is still unknown. In this study, we established an AAN model in vivo, a coculture system of macrophages and TECs, and a macrophage/TEC conditioned media culture model in vitro. We found that macrophage infiltration promoted injury, oxidative stress, and apoptosis in TECs. Furthermore, the role of macrophages in AAN was dependent on macrophage-derived extracellular vesicles (EVs). Importantly, we found that macrophage-derived, LRG1-enriched EVs induced TEC injury and apoptosis via a TGFβR1-dependent process. This study may help design a better therapeutic strategy to treat AAN patients.
马兜铃酸肾病(AAN)是由某些草药引起的进行性肾脏疾病,但目前的治疗方法仍无效。我们之前发现,富含亮氨酸的α-2-糖蛋白 1(LRG1),作为一种调节细胞过程的蛋白,在肾脏损伤模型中发挥着重要作用。然而,LRG1 调节 AAN 的潜在机制尚不清楚。在本研究中,我们在体内建立了 AAN 模型、巨噬细胞和 TEC 共培养系统以及体外巨噬细胞/TEC 条件培养基培养模型。我们发现,巨噬细胞浸润促进了 TEC 的损伤、氧化应激和细胞凋亡。此外,巨噬细胞在 AAN 中的作用依赖于巨噬细胞衍生的细胞外囊泡(EVs)。重要的是,我们发现巨噬细胞衍生的富含 LRG1 的 EVs 通过 TGFβR1 依赖性过程诱导 TEC 损伤和细胞凋亡。本研究可能有助于设计更好的治疗策略来治疗 AAN 患者。